+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Peripheral Blood Mononuclear Cells Market, by Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, Peripheral Blood Mononuclear Cell Isolation & Viability Kits), by Application, by Technique, by Source, by Region, Competition, Forecast & Opportunities, 2025

  • PDF Icon

    Report

  • December 2020
  • Region: Global
  • TechSci Research
  • ID: 5031353
UP TO OFF until Dec 31st 2022
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The global market for peripheral blood mononuclear cells (PBMC) was valued at USD 172.29 Million in 2019 and is projected to grow at a CAGR of 8.46% during 2020 - 2025. The PBMC are crucial to carry out the biology and pathology related studies as well as in clinical research. Besides, PBMCs are also utilized in research related to fatal diseases, immunology, vaccine development, etc. However, high cost of PBMCs related studies might act as a challenge for the adoption of technology, especially in developing economies.

The Global Peripheral Blood Mononuclear Cells Market is segmented based on product, application, technique, source, and region. The product segment is further divided into cryopreserved or frozen PBMC, cultured or fresh PBMC and peripheral blood mononuclear cell isolation & viability kits. As of 2019, the cryopreserved PBMC or the frozen PBMC segment held the dominant market share as they can be used for longer durations of time if stored carefully at lower temperatures.

Based on regional analysis, North America accounted for the largest market share in the year 2019, on the back of a number of pre-existing peripheral blood mononuclear cells-based companies in the region. The economy of the region is also rich enough, which makes it easier to carry out the complex and costly R&D procedures.

Major players operating in the Global Peripheral Blood Mononuclear Cells Market include Thermo Fisher Scientific Inc., Merck & Co., Inc., Corning Incorporate, Bio-Rad Laboratories, Inc., Cellero, LLC, Life Technologies (India) Pvt. Ltd., Cell Applications, Inc., DAPCEL, Inc., Creative Bioarray, iXCells Biotechnologies USA, LLC, Miltenyi Biotec B.V. & CO. KG, STEMCELL Technologies Inc., Precision Medicine Group, LLC., StemExpress, LLC, HemaCare Corporation, BioVision, Inc., BioLegend, Inc., BioIVT LLC, Biopredic International, Zen-Bio Inc., etc.

Years considered for this report:
  • Historical Years: 2015 - 2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021 - 2025

Objective of the Study:
  • To analyze and forecast the market size of the Global Peripheral Blood Mononuclear Cells Market.
  • To classify and forecast the Global Peripheral Blood Mononuclear Cells Market based on product, application, technique, source, and region.
  • To identify drivers and challenges for the Global Peripheral Blood Mononuclear Cells Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Peripheral Blood Mononuclear Cells Market.
  • To conduct pricing analysis for the Global Peripheral Blood Mononuclear Cells Market.
  • To identify and analyze the profile of leading players operating in the Global Peripheral Blood Mononuclear Cells Market.

The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of leading market players across the globe. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the research organizations and companies which could not be identified due to the limitations of secondary research. The publisher analyzed the research organizations and companies, and presence of all major players across the globe.

The publisher calculated the market size of the Global Peripheral Blood Mononuclear Cells Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Biotechnology and pharma companies and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to peripheral blood mononuclear cells
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as research organizations & companies and partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:

In this report, the Global Peripheral Blood Mononuclear Cells Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Product:
  • Cryopreserved or Frozen PBMC
  • Cultured or Fresh PBMC
  • Peripheral Blood Mononuclear Cell Isolation & Viability Kits

Market, By Application:
  • Immunology
  • Infectious disease
  • Hematology
  • Others

Market, By Technique:
  • Density gradient centrifugation process
  • Leukapheresis

Market, By Source:
  • Human
  • Animals

Market, By Region:
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Singapore
  • Australia
  • Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • North America
  • United States
  • Mexico
  • Canada
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle east & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Peripheral Blood Mononuclear Cells Market.

Available Customizations:
With the given market data, the publisher offers customizations according to a client’s specific needs.

Table of Contents

1. Product Overview2. Research Methodology3. Impact of COVID-19 on Global Peripheral Blood Mononuclear Cells Market4. Executive Summary
5. Voice of Customer
5.1. By Type of Product
5.2. By Type of Technique
5.3. Type of Application for Which PBMCs Are Used
5.4. Factors Driving Market Growth
6. Global Peripheral Blood Mononuclear Cells Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Cryopreserved or Frozen PBMC, Cultured or Fresh PBMC, Peripheral Blood Mononuclear Cell Isolation & Viability Kits)
6.2.2. By Application (Immunology, Infectious disease, Hematology and others)
6.2.3. By Technique (Density gradient centrifugation process, Leukapheresis)
6.2.4. By Source (Human, Animals)
6.2.5. By Company (2019)
6.2.6. By Region
6.3. Product Market Map
7. Asia-Pacific Peripheral Blood Mononuclear Cells Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By Technique
7.2.4. By Source
7.2.5. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Peripheral Blood Mononuclear Cells Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Technique
7.3.1.2.4. By Source
7.3.2. India Peripheral Blood Mononuclear Cells Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Technique
7.3.2.2.4. By Source
7.3.3. Japan Peripheral Blood Mononuclear Cells Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Technique
7.3.3.2.4. By Source
7.3.4. South Korea Peripheral Blood Mononuclear Cells Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By Technique
7.3.4.2.4. By Source
7.3.5. Singapore Peripheral Blood Mononuclear Cells Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By Technique
7.3.5.2.4. By Source
7.3.6. Australia Peripheral Blood Mononuclear Cells Market Outlook
7.3.6.1. Market Size & Forecast
7.3.6.1.1. By Value
7.3.6.2. Market Share & Forecast
7.3.6.2.1. By Product
7.3.6.2.2. By Application
7.3.6.2.3. By Technique
7.3.6.2.4. By Source
8. Europe Peripheral Blood Mononuclear Cells Market Outlook
8.1. Market Size & Forecast
8.2. Market Size & Forecast
8.2.1. By Value
8.3. Market Share & Forecast
8.3.1. By Product
8.3.2. By Application
8.3.3. By Technique
8.3.4. By Source
8.3.5. By Country
8.4. Europe: Country Analysis
8.4.1. France Peripheral Blood Mononuclear Cells Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Product
8.4.1.2.2. By Application
8.4.1.2.3. By Technique
8.4.1.2.4. By Source
8.4.2. Germany Peripheral Blood Mononuclear Cells Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Product
8.4.2.2.2. By Application
8.4.2.2.3. By Technique
8.4.2.2.4. By Source
8.4.3. United Kingdom Peripheral Blood Mononuclear Cells Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Product
8.4.3.2.2. By Application
8.4.3.2.3. By Technique
8.4.3.2.4. By Source
8.4.4. Italy Peripheral Blood Mononuclear Cells Market Outlook
8.4.4.1. Market Size & Forecast
8.4.4.1.1. By Value
8.4.4.2. Market Share & Forecast
8.4.4.2.1. By Product
8.4.4.2.2. By Application
8.4.4.2.3. By Technique
8.4.4.2.4. By Source
9. North America Peripheral Blood Mononuclear Cells Market Outlook
9.1. Market Size & Forecast
9.2. Market Size & Forecast
9.2.1. By Value
9.3. Market Share & Forecast
9.3.1. By Product
9.3.2. By Application
9.3.3. By Technique
9.3.4. By Source
9.3.5. By Country
9.4. North America: Country Analysis
9.4.1. United States Peripheral Blood Mononuclear Cells Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Product
9.4.1.2.2. By Application
9.4.1.2.3. By Technique
9.4.1.2.4. By Source
9.4.2. Mexico Peripheral Blood Mononuclear Cells Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Product
9.4.2.2.2. By Application
9.4.2.2.3. By Technique
9.4.2.2.4. By Source
9.4.3. Canada Peripheral Blood Mononuclear Cells Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Product
9.4.3.2.2. By Application
9.4.3.2.3. By Technique
9.4.3.2.4. By Source
10. South America Peripheral Blood Mononuclear Cells Market Outlook
10.1. Market Size & Forecast
10.2. Market Size & Forecast
10.2.1. By Value
10.3. Market Share & Forecast
10.3.1. By Product
10.3.2. By Application
10.3.3. By Technique
10.3.4. By Source
10.3.5. By Country
10.4. South America: Country Analysis
10.4.1. Brazil Peripheral Blood Mononuclear Cells Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1. By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1. By Product
10.4.1.2.2. By Application
10.4.1.2.3. By Technique
10.4.1.2.4. By Source
10.4.2. Argentina Peripheral Blood Mononuclear Cells Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1. By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1. By Product
10.4.2.2.2. By Application
10.4.2.2.3. By Technique
10.4.2.2.4. By Source
10.4.3. Colombia Peripheral Blood Mononuclear Cells Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1. By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1. By Product
10.4.3.2.2. By Application
10.4.3.2.3. By Technique
10.4.3.2.4. By Source
11. Middle East and Africa Peripheral Blood Mononuclear Cells Market Outlook
11.1. Market Size & Forecast
11.2. Market Size & Forecast
11.2.1. By Value
11.3. Market Share & Forecast
11.3.1. By Product
11.3.2. By Application
11.3.3. By Technique
11.3.4. By Source
11.3.5. By Country
11.4. MEA: Country Analysis
11.4.1. South Africa Peripheral Blood Mononuclear Cells Market Outlook
11.4.1.1. Market Size & Forecast
11.4.1.1.1. By Value
11.4.1.2. Market Share & Forecast
11.4.1.2.1. By Product
11.4.1.2.2. By Application
11.4.1.2.3. By Technique
11.4.1.2.4. By Source
11.4.2. Saudi Arabia Peripheral Blood Mononuclear Cells Market Outlook
11.4.2.1. Market Size & Forecast
11.4.2.1.1. By Value
11.4.2.2. Market Share & Forecast
11.4.2.2.1. By Product
11.4.2.2.2. By Application
11.4.2.2.3. By Technique
11.4.2.2.4. By Source
11.4.3. UAE Peripheral Blood Mononuclear Cells Market Outlook
11.4.3.1. Market Size & Forecast
11.4.3.1.1. By Value
11.4.3.2. Market Share & Forecast
11.4.3.2.1. By Product
11.4.3.2.2. By Application
11.4.3.2.3. By Technique
11.4.3.2.4. By Source
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments14. Clinical Trials
15. Competitive Landscape
15.1. Competition Outlook
15.2. Players Profiled (Leading Companies)
15.2.1. Thermo Fisher Scientific Inc.
15.2.2. Merck & Co., Inc.
15.2.3. Corning Incorporate
15.2.4. Bio-Rad Laboratories, Inc.
15.2.5. Cellero, LLC
15.2.6. Life Technologies (India) Pvt. Ltd.
15.2.7. Cell Applications, Inc.
15.2.8. DAPCEL, Inc.
15.2.9. Creative Bioarray
15.2.10. iXCells Biotechnologies USA, LLC
15.2.11. Miltenyi Biotec B.V. & CO. KG
15.2.12. STEMCELL Technologies Inc.
15.2.13. Precision Medicine Group, LLC.
15.2.14. StemExpress, LLC
15.2.15. HemaCare Corporation
15.2.16. BioVision, Inc.
15.2.17. BioLegend, Inc.
15.2.18. BioIVT LLC
15.2.19. Biopredic International
15.2.20. Zen-Bio Inc.
16. Strategic Recommendation17. About the Publisher & Disclaimer
List of Figures
Figure 1: Global Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 2: Global Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 3: Global Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 4: Global Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 5: Global Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 6: Global Peripheral Blood Mononuclear Cells Market Share, By Company, By Value, 2019
Figure 7: Global Peripheral Blood Mononuclear Cells Market Share, By Region, By Value, 2019 & 2025F
Figure 8:
Global Peripheral Blood Mononuclear Cells Market Map, By Product - Market Size (USD Million) &
Growth Rate (%)
Figure 9:
Global Peripheral Blood Mononuclear Cells Market Map, By Application - Market Size (USD Million) &
Growth Rate (%)
Figure 10:
Global Peripheral Blood Mononuclear Cells Market Map, By Technique - Market Size (USD Million) &
Growth Rate (%)
Figure 11:
Global Peripheral Blood Mononuclear Cells Market Map, By Source - Market Size (USD Million) &
Growth Rate (%)
Figure 12:
Global Peripheral Blood Mononuclear Cells Market Map, By Region - Market Size (USD Million) &
Growth Rate (%)
Figure 13: North America Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 14: North America Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 15: North America Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 16: North America Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 17: North America Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 18: North America Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
Figure 19: United States Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 20: New Cancer Cases in United States, (%), 2019
Figure 21: United States Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 22: United States Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 23: United States Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 24: United States Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 25: Canada Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 26: Canada Hospital Establishments, By Region, 2019 (Units)
Figure 27: Canada Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 28: Canada Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 29: Canada Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 30: Canada Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 31: Mexico Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 32: Mexico Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
Figure 33: Mexico Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 34: Mexico Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 35: Mexico Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 36: Mexico Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 37: Europe Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 38: Europe Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 39: Europe Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 40: Europe Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 41: Europe Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 42: Europe Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
Figure 43: Germany Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 44: New Cancer Cases in Germany, (%), 2019
Figure 45: Germany Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 46: Germany Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 47: Germany Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 48: Germany Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 49: France Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 50: France Healthcare Spending, By Value (USD Per Capita), 2015-2019
Figure 51: France Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 52: France Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 53: France Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 54: France Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 55: United Kingdom Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 56: New Cancer Cases in United Kingdom, (%), 2019
Figure 57: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 58: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 59: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 60: United Kingdom Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 61: Italy Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 62: Italy Total Health Expenditure as a Share of GDP (%), 2015 - 2019
Figure 63: Italy Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 64: Italy Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 65: Italy Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 66: Italy Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 67: Asia-Pacific Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 68: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 69: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 70: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 71: Asia-Pacific Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 72: Asia-Pacific Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
Figure 73: China Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 74: New Cancer Cases in China (%), 2019
Figure 75: China Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 76: China Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 77: China Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 78: China Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 79: Japan Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 80: Japan Total Health Expenditure as a Share of GDP (%), 2015 - 2019
Figure 81: Japan Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 82: Japan Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 83: Japan Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 84: Japan Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 85: India Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 86: Total Number of Hospitals in India, 2019
Figure 87: India Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 88: India Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 89: India Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 90: India Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 91: South Korea Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 92: New Cancer Cases in South Korea (%), 2019
Figure 93: South Korea Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 94: South Korea Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 95: South Korea Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 96: South Korea Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 97: Australia Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 98: % of Public and Private Hospitals in Australia, 2019
Figure 99: Australia Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 100: Australia Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 101: Australia Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 102: Australia Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 103: Singapore Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 104: New Cancer Cases in Singapore (%), 2019
Figure 105: Singapore Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 106: Singapore Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 107: Singapore Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 108: Singapore Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 109: South America Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 110: South America Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 111: South America Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 112: South America Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 113: South America Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 114: South America Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
Figure 115: Brazil Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 116: Total Number of Hospitals in Brazil, 2015-2019s
Figure 117: Brazil Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 118: Brazil Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 119: Brazil Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 120: Brazil Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 121: Argentina Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 122: Argentina Health Expenditure (% of GDP), 2015-2019
Figure 123: Argentina Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 124: Argentina Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 125: Argentina Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 126: Argentina Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 127: Colombia Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 128: New Cancer Cases in Colombia (%), 2019
Figure 129: Colombia Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 130: Colombia Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 131: Colombia Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 132: Colombia Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 133: Middle East & Africa Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 134:
Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Product, By Value,
2015-2025F
Figure 135:
Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Application, By Value,
2015-2025F
Figure 136:
Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value,
2015-2025F
Figure 137: Middle East & Africa Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 138: Middle East and Africa Peripheral Blood Mononuclear Cells Market Size, By Country, 2015-2025F
Figure 139: UAE Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 140: UAE Health Expenditure (% of GDP), 2015-2019
Figure 141: UAE Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 142: UAE Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 143: UAE Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 144: UAE Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 145: Saudi Arabia Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 146: Total Number of Hospitals in Saudi Arabia, 2015-2019
Figure 147: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 148: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 149: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 150: Saudi Arabia Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F
Figure 151: South Africa Peripheral Blood Mononuclear Cells Market Size, By Value, 2015-2025F (USD Million)
Figure 152: South Africa Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)
Figure 153: South Africa Peripheral Blood Mononuclear Cells Market Share, By Product, By Value, 2015-2025F
Figure 154: South Africa Peripheral Blood Mononuclear Cells Market Share, By Application, By Value, 2015-2025F
Figure 155: South Africa Peripheral Blood Mononuclear Cells Market Share, By Technique, By Value, 2015-2025F
Figure 156: South Africa Peripheral Blood Mononuclear Cells Market Share, By Source, By Value, 2015-2025F

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Thermo Fisher Scientific Inc.
  • Merck & Co., Inc.
  • Corning Incorporate
  • Bio-Rad Laboratories, Inc.
  • Cellero, LLC
  • Life Technologies (India) Pvt. Ltd.
  • Cell Applications, Inc.
  • DAPCEL, Inc.
  • Creative Bioarray
  • iXCells Biotechnologies USA, LLC
  • Miltenyi Biotec B.V. & CO. KG
  • STEMCELL Technologies Inc.
  • Precision Medicine Group, LLC.
  • StemExpress, LLC
  • HemaCare Corporation
  • BioVision, Inc.
  • BioLegend, Inc.
  • BioIVT LLC
  • Biopredic International
  • Zen-Bio Inc.